Shedding light
on blood flow
Shedding light
on blood flow
Shedding light
on blood flow
We develop a microfluidic-based platform to advance hematological diagnostics, assist therapy decision-making and improve patient safety.
Our technology enables a high-throughput, AI-powered assessment of the morphology and functionality of blood on a cellular level.
Technology



Technology
Over 25 trillion red blood cells travel through our bodies every minute. Their shape is a highly sensitive parameter for both intrinsic cell properties and external influences. Erysense utilizes red blood cell shape features as a biomarker.



Advantages
Small sample volume
Erysense requires only one drop of blood, avoiding the need of specialized personnel for sampling and minimizing patient blood loss.


Analysis on a single-cell level
The shape of red blood cells is highly influenced by the intrinsic cell properties and external conditions. Erysense enables the examination of such effects on the morphology of individual cells at high-throughput.
Versatility
Erysense enables advanced hematological diagnosis, individualized therapy, and in-vitro drug testing.

Advantages

Small sample volume
Erysense requires only one drop of blood, avoiding the need of specialized personnel for sampling and minimizing patient blood loss.

Analysis on a single-cell level
The shape of red blood cells is highly influenced by the intrinsic cell properties and external conditions. Erysense enables the examination of such effects on the morphology of individual cells at high-throughput.

Versatility
Erysense enables advanced hematological diagnosis, individualized therapy, and in-vitro drug testing.
Applications

Blood quality assessment for transfusion medicine

Advanced hematological diagnostics

research

In-vitro testing for drug development

Biomedical technologies, e.g., cell-based drug delivery

Blood quality
assessment for
transfusion
medicine

hematological
diagnostics

Blood and cell
research

testing for drug
development

technologies, e.g.,
cell-based
drug delivery
Meet our team
This diversified background motivates us to unify our strengths for a mutual goal: setting new standards in hematology with our Erysense Technology.
Founders
Dr. Stephan Quint
Dr. Greta Simionato
Dr. Steffen M. Recktenwald
Students
M. Sc. Marcelle Lopes
Leah Rolinger
Advisory Board
Prof. Lars Kaestner
Dr. Martin Gitzinger
Patrick Klein
Sebastian Rohde
Contact
info(at)cysmic.de
Auf der Trift 1
66127 Saarbrücken